CTOs on the Move

Faze Medicines

www.fazemed.com

 
Faze Medicines is a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.fazemed.com
  • 215 First Street Suite 440
    Cambridge, MA USA 02142
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Faze Medicines raised $81M on 12/10/2020

Similar Companies

Lumen Bioscience

Lumen Bioscience develops oral antibody therapeutics.

Kosan Biosciences

Kosan Biosciences Incorporated is a Hayward, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mesoblast

Mesoblast is a world leader in developing innovative cellular medicines. We have established what we believe is the industry`s most clinically advanced and diverse portfolio of cell-based products with five programs, two of which are partnered, in active Phase 3 clinical studies or Phase 3-ready, and four programs in Phase 2. All our clinical programs target significant, under-served therapeutic areas including cardiac diseases, spine orthopedic disorders, oncology and hematology diseases, and immune-mediated and inflammatory conditions.

Arresto BioSciences

Arresto BioSciences is a Palo Alto, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Molecular Designs

Better products. Better service. MOLECULAR DESIGNS Molecular Designs is a team of doctors and scientists working to advance molecular diagnostics. We do this by developing, producing, and supplying multiplex assays for molecular testing ...